South China Morning Post · General

As China’s biotech firms shift gears, can AI floor the accelerator?

· By Julie Zhang
Story summary

Chinese biotech firms are striking big global deals as drug makers, but could artificial intelligence take them to the next level?

Read at South China Morning Post

Opens the original publisher in a new tab. Full articles belong to their publishers; a subscription may be required.

Your local edition.

Choose a timezone for story timestamps and date filters.